On Invalid Date, Steris (NYSE: STE) reported Q3 2022 earnings per share (EPS) of -$3.15, up 550% year over year. Total Steris earnings for the quarter were -$315.29 million. In the same quarter last year, Steris's earnings per share (EPS) was $0.70.
On Invalid Date, Steris (NYSE: STE) reported Q3 2022 revenue of $1.20 billion up 0.3% year over year. In the same quarter last year, Steris's revenue was $1.20 billion.
What was STE's revenue growth in the past year?
As of Q1 2023, Steris's revenue has grown 24.14% year over year. This is 14.71 percentage points higher than the US Medical Instruments & Supplies industry revenue growth rate of 9.43%. Steris's revenue in the past year totalled $4.78 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.